Global Gene Silencing Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Gene Silencing Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Gene Silencing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Transcriptional
  • 1.4.3 Post-transcriptional
  • 1.4.4 Meiotic
• 1.5 Market by Application
  • 1.5.1 Global Gene Silencing Market Share by Application: 2020 VS 2026
  • 1.5.2 Cancer Treatment
  • 1.5.3 Neurological Diseases Treatment
  • 1.5.4 Scar Treatment
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Gene Silencing Market Perspective (2015-2026)
• 2.2 Gene Silencing Growth Trends by Regions
  • 2.2.1 Gene Silencing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Gene Silencing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Gene Silencing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Gene Silencing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Gene Silencing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Gene Silencing Players by Market Size
  • 3.1.1 Global Top Gene Silencing Players by Revenue (2015-2020)
  • 3.1.2 Global Gene Silencing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Gene Silencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Gene Silencing Market Concentration Ratio
  • 3.2.1 Global Gene Silencing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Gene Silencing Revenue in 2019
• 3.3 Gene Silencing Key Players Head office and Area Served
• 3.4 Key Players Gene Silencing Product Solution and Service
• 3.5 Date of Enter into Gene Silencing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Gene Silencing Historic Market Size by Type (2015-2020)
• 4.2 Global Gene Silencing Forecasted Market Size by Type (2021-2026)

5 Gene Silencing Breakdown Data by Application (2015-2026)

• 5.1 Global Gene Silencing Market Size by Application (2015-2020)
• 5.2 Global Gene Silencing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Gene Silencing Market Size (2015-2020)
• 6.2 Gene Silencing Key Players in North America (2019-2020)
• 6.3 North America Gene Silencing Market Size by Type (2015-2020)
• 6.4 North America Gene Silencing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Gene Silencing Market Size (2015-2020)
• 7.2 Gene Silencing Key Players in Europe (2019-2020)
• 7.3 Europe Gene Silencing Market Size by Type (2015-2020)
• 7.4 Europe Gene Silencing Market Size by Application (2015-2020)

8 China

• 8.1 China Gene Silencing Market Size (2015-2020)
• 8.2 Gene Silencing Key Players in China (2019-2020)
• 8.3 China Gene Silencing Market Size by Type (2015-2020)
• 8.4 China Gene Silencing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Gene Silencing Market Size (2015-2020)
• 9.2 Gene Silencing Key Players in Japan (2019-2020)
• 9.3 Japan Gene Silencing Market Size by Type (2015-2020)
• 9.4 Japan Gene Silencing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Gene Silencing Market Size (2015-2020)
• 10.2 Gene Silencing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Gene Silencing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Gene Silencing Market Size by Application (2015-2020)

11 India

• 11.1 India Gene Silencing Market Size (2015-2020)
• 11.2 Gene Silencing Key Players in India (2019-2020)
• 11.3 India Gene Silencing Market Size by Type (2015-2020)
• 11.4 India Gene Silencing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Gene Silencing Market Size (2015-2020)
• 12.2 Gene Silencing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Gene Silencing Market Size by Type (2015-2020)
• 12.4 Central & South America Gene Silencing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Alnylam Pharmaceuticals
  • 13.1.1 Alnylam Pharmaceuticals Company Details
  • 13.1.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
  • 13.1.3 Alnylam Pharmaceuticals Gene Silencing Introduction
  • 13.1.4 Alnylam Pharmaceuticals Revenue in Gene Silencing Business (2015-2020))
  • 13.1.5 Alnylam Pharmaceuticals Recent Development
• 13.2 Benitec Biopharma
  • 13.2.1 Benitec Biopharma Company Details
  • 13.2.2 Benitec Biopharma Business Overview and Its Total Revenue
  • 13.2.3 Benitec Biopharma Gene Silencing Introduction
  • 13.2.4 Benitec Biopharma Revenue in Gene Silencing Business (2015-2020)
  • 13.2.5 Benitec Biopharma Recent Development
• 13.3 Arrowhead Pharmaceuticals
  • 13.3.1 Arrowhead Pharmaceuticals Company Details
  • 13.3.2 Arrowhead Pharmaceuticals Business Overview and Its Total Revenue
  • 13.3.3 Arrowhead Pharmaceuticals Gene Silencing Introduction
  • 13.3.4 Arrowhead Pharmaceuticals Revenue in Gene Silencing Business (2015-2020)
  • 13.3.5 Arrowhead Pharmaceuticals Recent Development
• 13.4 Merck Group
  • 13.4.1 Merck Group Company Details
  • 13.4.2 Merck Group Business Overview and Its Total Revenue
  • 13.4.3 Merck Group Gene Silencing Introduction
  • 13.4.4 Merck Group Revenue in Gene Silencing Business (2015-2020)
  • 13.4.5 Merck Group Recent Development
• 13.5 Eli Lilly (Dicerna Pharmaceuticals)
  • 13.5.1 Eli Lilly (Dicerna Pharmaceuticals) Company Details
  • 13.5.2 Eli Lilly (Dicerna Pharmaceuticals) Business Overview and Its Total Revenue
  • 13.5.3 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Introduction
  • 13.5.4 Eli Lilly (Dicerna Pharmaceuticals) Revenue in Gene Silencing Business (2015-2020)
  • 13.5.5 Eli Lilly (Dicerna Pharmaceuticals) Recent Development
• 13.6 Monsanto (Bayer AG)
  • 13.6.1 Monsanto (Bayer AG) Company Details
  • 13.6.2 Monsanto (Bayer AG) Business Overview and Its Total Revenue
  • 13.6.3 Monsanto (Bayer AG) Gene Silencing Introduction
  • 13.6.4 Monsanto (Bayer AG) Revenue in Gene Silencing Business (2015-2020)
  • 13.6.5 Monsanto (Bayer AG) Recent Development
• 13.7 RXi Pharmaceuticals
  • 13.7.1 RXi Pharmaceuticals Company Details
  • 13.7.2 RXi Pharmaceuticals Business Overview and Its Total Revenue
  • 13.7.3 RXi Pharmaceuticals Gene Silencing Introduction
  • 13.7.4 RXi Pharmaceuticals Revenue in Gene Silencing Business (2015-2020)
  • 13.7.5 RXi Pharmaceuticals Recent Development
• 13.8 Silence Therapeutics plc
  • 13.8.1 Silence Therapeutics plc Company Details
  • 13.8.2 Silence Therapeutics plc Business Overview and Its Total Revenue
  • 13.8.3 Silence Therapeutics plc Gene Silencing Introduction
  • 13.8.4 Silence Therapeutics plc Revenue in Gene Silencing Business (2015-2020)
  • 13.8.5 Silence Therapeutics plc Recent Development
• 13.9 Idera Pharmaceuticals
  • 13.9.1 Idera Pharmaceuticals Company Details
  • 13.9.2 Idera Pharmaceuticals Business Overview and Its Total Revenue
  • 13.9.3 Idera Pharmaceuticals Gene Silencing Introduction
  • 13.9.4 Idera Pharmaceuticals Revenue in Gene Silencing Business (2015-2020)
  • 13.9.5 Idera Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer